Dabrafenib is a potent BRAF inhibitor. It affects MAPK/ERK signaling by binding to BRAF, inhibiting tumor cell proliferation.
Dabrafenib (GSK2118436) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Dabrafenib (GSK2118436) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.